Heart Test Laboratories, Inc. (NASDAQ:HSCS) Short Interest Update

Heart Test Laboratories, Inc. (NASDAQ:HSCSGet Rating) was the recipient of a large increase in short interest in the month of May. As of May 15th, there was short interest totalling 117,300 shares, an increase of 264.3% from the April 30th total of 32,200 shares. Currently, 1.8% of the shares of the company are short sold. Based on an average daily volume of 87,500 shares, the days-to-cover ratio is currently 1.3 days.

Hedge Funds Weigh In On Heart Test Laboratories

Institutional investors have recently made changes to their positions in the stock. Jane Street Group LLC purchased a new stake in shares of Heart Test Laboratories in the second quarter valued at $28,000. Oliver Lagore Vanvalin Investment Group purchased a new stake in shares of Heart Test Laboratories in the third quarter valued at $30,000. Chapin Davis Inc. purchased a new stake in shares of Heart Test Laboratories in the fourth quarter valued at $46,000. AE Wealth Management LLC grew its position in shares of Heart Test Laboratories by 516.8% in the fourth quarter. AE Wealth Management LLC now owns 154,204 shares of the company’s stock valued at $130,000 after purchasing an additional 129,204 shares during the period. Finally, Tradition Wealth Management LLC purchased a new stake in shares of Heart Test Laboratories in the fourth quarter valued at $34,000. 0.82% of the stock is owned by institutional investors and hedge funds.

Heart Test Laboratories Stock Performance

HSCS stock traded down $0.20 during midday trading on Friday, hitting $1.06. 169,928 shares of the stock were exchanged, compared to its average volume of 1,668,625. The stock’s 50-day moving average price is $0.97 and its 200-day moving average price is $1.23. Heart Test Laboratories has a fifty-two week low of $0.71 and a fifty-two week high of $6.00.

Heart Test Laboratories (NASDAQ:HSCSGet Rating) last issued its quarterly earnings data on Thursday, March 16th. The company reported ($0.16) earnings per share (EPS) for the quarter.

Analysts Set New Price Targets

Separately, Ascendiant Capital Markets began coverage on Heart Test Laboratories in a research report on Monday, January 30th. They issued a “buy” rating and a $3.30 target price for the company.

About Heart Test Laboratories

(Get Rating)

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information.

Read More

Receive News & Ratings for Heart Test Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heart Test Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.